Sandu Pharmaceuticals Income Statement

Health Care & Life Sciences » Pharmaceuticals | Sandu Pharmaceuticals Ltd.

Sandu Pharmaceuticals Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.

2014

2015

2016

2017

2018

2019

Sales/Revenue

345,166.80

379,835.30

388,350.10

425,486.90

490,159.00

494,246

Cost of Goods Sold (COGS) incl. D&A

260,244.00

273,631.70

278,573.30

319,475.30

349,325.00

324,718

Gross Income

84,922.80

106,203.60

109,776.80

106,011.60

140,834.00

169,528

SG&A Expense

67,436.70

88,370.50

85,113.10

84,499.30

122,190.00

154,947

EBIT

16,040.40

16,794.20

19,441.10

18,644.00

14,581

Unusual Expense

521.40

1,826.90

2.80

927.90

Non Operating Income/Expense

2,440.50

402.00

831.60

5.80

1,218.00

5,740

Interest Expense

10,428.40

13,528.10

16,177.40

14,634.80

12,310.00

10,118

Pretax Income

8,232.10

6,287.40

6,794.40

9,213.60

7,552.00

10,177

Income Tax

3,270.20

2,150.80

1,415.50

4,975.70

1,937.00

3,814

Consolidated Net Income

4,961.90

4,136.60

5,378.90

4,237.90

5,615.00

6,363

Net Income

4,961.90

4,136.60

5,378.90

4,237.90

5,615.00

6,363

Net Income After Extraordinaries

4,961.90

4,136.60

5,378.90

4,237.90

5,615.00

6,363

Net Income Available to Common

4,961.90

4,136.60

5,378.90

4,237.90

5,615.00

6,363

EPS (Basic)

0.70

0.58

0.76

0.60

0.79

0.94

Basic Shares Outstanding

7,081.00

EPS (Diluted)

0.70

0.58

0.76

0.60

Diluted Shares Outstanding

7,081.00

EBITDA

21,400.80

22,539.60

28,725.10

26,657.70

24,668.00

20,939

Other Operating Expense

1,445.70

1,038.90

2,869.40

2,071.20

Non-Operating Interest Income

701.00

792.40

348.70

3,473.50

About Sandu Pharmaceuticals

View Profile

Address	Sandu Nagar Mumbai Maharashtra 400071 India
Employees	-
Website	http://www.sandu.in
Updated	07/08/2019
Sandu Pharmaceuticals Ltd. manufactures and markets ayurvedic medicines. It offers specialty products including Berbenteron Pediatric Suspension, Berbenteron Compound Tablets, Bilagyl, Debix, Elegance Oil, Ephenin, Haemol Forte, Madiphal Rasayan, OSTEON-D, and others. The company was founded on May 10, 1899 and is headquartered in Mumbai, India .

Sandu Pharmaceuticals Ltd. | Income Statement

About Sandu Pharmaceuticals

StatInvestor